Drug Positioning and Repositioning
We profile compounds, whether in late development, in the market or at the generic phase and match them with diseases to find new uses for drugs or new therapies for indications of interest. more...
Personalized Medicine
Given the holistic context of N=1 patient, what drug regimen makes most sense, from both a benefit and risk perspective?
In-Stream Trial Analytics and De-risking
We correlate trial data in real time and look for signal/noise that may derail a trial. We also run this in reverse, to help identify the right subpopulations. more...
New Target Biology
We parse diseases and identify unanticipated mechanisms for new generation druggable targets. We then combine with repositioning. more...
Real-world AI in healthcare, and beyond
Healthcare stakeholders
-
"Perhaps one of the most innovative companies of #AI in #healthcare. Very proud to have collaborated."
Spiros Liolis AI, Blockchain and Digital Transformation Business Development Manager & CTO, Hewlett Packard Enterprise -
"Hard to believe it’s been 10 years changing the world of healthcare. I am so grateful to be working with you and the team at Biovista. Keep on track, change the world. #ThankYou"
Cliff Farah President, The Beacon Group -
"Exciting technology for providing quantum leaps in healthcare-related analytics. The Oral Roberts University data analytics research team is thrilled to engage with Biovista in exploring the ramifications of Project Prodigy."
Stephen Wheat Professor of Computer Science and Director of HPC, Oral Roberts University.